171 related articles for article (PubMed ID: 9195219)
1. Establishment of parameters for optimal transduction efficiency and antitumor effects with purified high-titer HSV-TK retroviral vector in established solid tumors.
Smiley WR; Laubert B; Howard BD; Ibañez C; Fong TC; Summers WS; Burrows FJ
Hum Gene Ther; 1997 May; 8(8):965-77. PubMed ID: 9195219
[TBL] [Abstract][Full Text] [Related]
2. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
3. An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo.
Lyons RM; Forry-Schaudies S; Otto E; Wey C; Patil-Koota V; Kaloss M; McGarrity GJ; Chiang YL
Cancer Gene Ther; 1995 Dec; 2(4):273-80. PubMed ID: 8548581
[TBL] [Abstract][Full Text] [Related]
4. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
[TBL] [Abstract][Full Text] [Related]
5. Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors.
Kruse CA; Roper MD; Kleinschmidt-DeMasters BK; Banuelos SJ; Smiley WR; Robbins JM; Burrows FJ
Cancer Gene Ther; 1997; 4(2):118-28. PubMed ID: 9080121
[TBL] [Abstract][Full Text] [Related]
6. Ablation of tumor cells in vivo by direct injection of HSV-thymidine kinase retroviral vector and ganciclovir therapy.
Howard BD; Kalthoff H; Fong TC
Ann N Y Acad Sci; 1999 Jun; 880():352-65. PubMed ID: 10415879
[TBL] [Abstract][Full Text] [Related]
7. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
8. Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications.
Paquin A; Jaalouk DE; Galipeau J
Hum Gene Ther; 2001 Jan; 12(1):13-23. PubMed ID: 11177538
[TBL] [Abstract][Full Text] [Related]
9. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors.
Ram Z; Culver KW; Walbridge S; Frank JA; Blaese RM; Oldfield EH
J Neurosurg; 1993 Sep; 79(3):400-7. PubMed ID: 8395592
[TBL] [Abstract][Full Text] [Related]
10. Retrovirus-mediated suicide gene transduction in the vitreous cavity of the eye: feasibility in prevention of proliferative vitreoretinopathy.
Kimura H; Sakamoto T; Cardillo JA; Spee C; Hinton DR; Gordon EM; Anderson WF; Ryan SJ
Hum Gene Ther; 1996 May; 7(7):799-808. PubMed ID: 8860832
[TBL] [Abstract][Full Text] [Related]
11. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
Cancer Gene Ther; 1999; 6(4):358-66. PubMed ID: 10419054
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir.
Oldfield EH; Ram Z; Culver KW; Blaese RM; DeVroom HL; Anderson WF
Hum Gene Ther; 1993 Feb; 4(1):39-69. PubMed ID: 8384892
[TBL] [Abstract][Full Text] [Related]
13. Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration.
Packer RJ; Raffel C; Villablanca JG; Tonn JC; Burdach SE; Burger K; LaFond D; McComb JG; Cogen PH; Vezina G; Kapcala LP
J Neurosurg; 2000 Feb; 92(2):249-54. PubMed ID: 10659011
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors.
Kun LE; Gajjar A; Muhlbauer M; Heideman RL; Sanford R; Brenner M; Walter A; Langston J; Jenkins J; Facchini S
Hum Gene Ther; 1995 Sep; 6(9):1231-55. PubMed ID: 8527482
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
Guan J; Ma L; Wei L
Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
[TBL] [Abstract][Full Text] [Related]
16. A more potent bystander cytocidal effect elicited by tumor cells expressing the herpes simplex virus-thymidine kinase gene than by fibroblast virus-producer cells in vitro.
Vrionis FD; Wu JK; Qi P; Cano W; Cherington V
J Neurosurg; 1995 Oct; 83(4):698-704. PubMed ID: 7674020
[TBL] [Abstract][Full Text] [Related]
17. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors.
Moolten FL; Wells JM
J Natl Cancer Inst; 1990 Feb; 82(4):297-300. PubMed ID: 2299679
[TBL] [Abstract][Full Text] [Related]
18. A combined gene delivery by co-transduction of adenoviral and retroviral vectors for cancer gene therapy.
Pan Y; Zhai P; Dashti AM; Wu S; Lin X; Wu M
Cancer Lett; 2002 Oct; 184(2):179-88. PubMed ID: 12127690
[TBL] [Abstract][Full Text] [Related]
19. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene.
Benedetti S; Dimeco F; Pollo B; Cirenei N; Colombo BM; Bruzzone MG; Cattaneo E; Vescovi A; Didonato S; Colombo MP; Finocchiaro G
Hum Gene Ther; 1997 Jul; 8(11):1345-53. PubMed ID: 9295129
[TBL] [Abstract][Full Text] [Related]
20. [Vesicular stomatitis virus G-protein retrovector mediated a herpes simplex virus thymidine kinase gene transduction and expression in the human retinal pigment epithelial cells].
Wang F; Wang HW; Lu DR; Xue JL; Zhang X
Zhonghua Yan Ke Za Zhi; 2003 Apr; 39(4):201-5. PubMed ID: 12882696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
